Sign in
Taking people in United StatesNo phase

Testing a non-invasive device to estimate central venous pressure in children

Tests a non-invasive ultrasound device, CPMX2, in children who already have a catheter.

Key facts

Who runs it
Compremium AG
Where
Washington D.C., United StatesSee the site
Trial code
Registry title
Non-invasive Central Venous Pressure Estimation in Pediatric Patients
Status
Recruiting
People taking part
100 people, planned
Started
10 Mar 2025
Planned end
31 Mar 2026
Type of study
Interventional
Treatments tested
  • CPMX2
Record updated
18 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and young people who already have a central venous catheter to measure central venous pressure, or who are having a cardiac catheterization. It tests a new device that measures this pressure without a catheter, using ultrasound.

Age
From birth to 21 years
Sex
Males and females can join
Earlier treatment
Must have a central venous catheter for central venous pressure monitoring as part of standard care, or be having a cardiac catheterization.

Main reasons for not taking part

  • Weight under 2.5kg (6 lb (3 kg)) at enrollment
  • Neck veins (both external jugular veins) not accessible because of vascular access or dressing
  • Skin lesions on both sides of the neck that rule out a neck ultrasound
  • Active bleeding
  • Clinically unstable, as judged by the attending physician and/or surgeon

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Provision of signed and dated informed consent form
  • Male or female
  • Age: birth to 21 years of age
  • Equipped with a central venous catheter (CVC) for central venous pressure (CVP) monitoring indication as part of standard of care, or undergoing cardiac catheterization

Who cannot take part

  • Active bleeding
  • Weight less than 2.5kg at the time of enrollment
  • Bilateral external jugular veins not accessible due to vascular access or dressing
  • Bilateral skin lesion contraindicating neck Ultrasound
  • Clinically unstable, per clinical assessment by attending physician and/or surgeon

Where in United States

  • Children's National HospitalWashington D.C., United StatesContact: Damon JudgesTaking people

About the trial

What the trial wants to find out

Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The proposed pilot study will evaluate safety and preliminary efficacy of a new non-invasive ultrasound-based venous occlusion pressure (VOP) monitoring device (CPMX2) in children equipped with an invasive catheter for CVP monitoring as part of standard of care.

The group in the trial

  • CPMX2 measurement armTreatment being tested

    CPMX2 measurements will be compared against invasive CVP measurements

    Treatment: CPMX2

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Non-invasive Central Venous Pressure Estimation in Pediatric Patients
Plain-language title
Testing a non-invasive device to estimate central venous pressure in childrenGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
18 September 2025